Veterinary Oncology Market Size, Share, Trends, Growth Outlook

Veterinary Oncology Market is estimated to increase at a growth rate of 10.8% CAGR over the forecast period from 2024 to 2030.

The global Veterinary Oncology Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Therapy (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Others), By Animal (Canine, Feline, Equine), By Cancer (Skin Cancers, Lymphomas, Sarcomas, Others).

An introduction to Veterinary Oncology Market in 2024

The Veterinary Oncology Market focuses on providing comprehensive diagnostic, therapeutic, and supportive care services for animals diagnosed with cancer. Veterinary oncology encompasses a range of treatment modalities, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapies, aimed at managing cancer in companion animals, livestock, and exotic species. Veterinary oncologists work closely with multidisciplinary teams to develop individualized treatment plans and support strategies that optimize patient outcomes and quality of life. With the increasing prevalence of cancer in animals and the growing demand for advanced oncology services, the veterinary oncology market experiences growth, driven by advancements in cancer research, early detection methods, and innovative treatment options, as well as the expanding role of palliative and hospice care in veterinary medicine.

Veterinary Oncology Market Trend: Increasing Prevalence of Cancer in Companion Animals

One prominent trend in the Veterinary Oncology market is the increasing prevalence of cancer in companion animals, driving demand for advanced diagnostic and therapeutic solutions to address the growing burden of oncological diseases in veterinary practice. Cancer is a leading cause of morbidity and mortality in dogs, cats, and other domesticated animals, with a wide range of tumor types affecting various anatomical sites. The rising incidence of cancer in companion animals can be attributed to factors such as longer lifespans, environmental exposures, genetic predispositions, and advances in veterinary medicine leading to improved cancer detection and diagnosis. As pet owners become more vigilant about their pets' health and well-being, there is a growing demand for veterinary oncology services, including early detection screenings, diagnostic imaging, surgery, chemotherapy, radiation therapy, and supportive care options. The trend towards increasing cancer prevalence in companion animals underscores the need for comprehensive oncology services and drives market growth and innovation in the Veterinary Oncology market.

Veterinary Oncology Market Driver: Advancements in Veterinary Oncology Research and Treatment

A significant driver in the Veterinary Oncology market is the continuous advancements in veterinary oncology research, diagnostic technologies, and treatment modalities aimed at improving cancer detection, diagnosis, and management outcomes in animal patients. Veterinary oncologists, researchers, and pharmaceutical companies are collaborating to develop innovative diagnostic tests, targeted therapies, immunotherapies, and supportive care interventions tailored to the unique needs of veterinary cancer patients. From molecular profiling and tumor biomarker analysis to precision medicine approaches and novel treatment protocols, there is a concerted effort to enhance the understanding of cancer biology and develop personalized treatment strategies for individual animals based on their tumor type, stage, and molecular characteristics. Additionally, advancements in imaging technologies such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) enable veterinarians to accurately stage tumors, monitor treatment responses, and assess disease progression in animal patients. The drive towards advancements in veterinary oncology research and treatment options fuels market growth and investment in the Veterinary Oncology market, offering new hope and improved outcomes for pets diagnosed with cancer.

Veterinary Oncology Market Opportunity: Development of Targeted Therapies and Immunotherapies

An emerging opportunity in the Veterinary Oncology market lies in the development of targeted therapies and immunotherapies specifically designed to combat cancer in companion animals, offering new treatment options and improved survival rates for veterinary cancer patients. While traditional cancer treatments such as surgery, chemotherapy, and radiation therapy remain essential components of veterinary oncology practice, there is increasing interest in targeted therapies that selectively target cancer cells while sparing normal tissues, minimizing side effects and enhancing treatment efficacy. Additionally, immunotherapy approaches such as monoclonal antibodies, cancer vaccines, and adoptive cell therapies hold promise for stimulating the immune system to recognize and attack tumor cells, harnessing the body's own defense mechanisms to fight cancer. Manufacturers, biotechnology companies, and academic institutions have the opportunity to collaborate on the development and commercialization of targeted therapies and immunotherapies for veterinary oncology applications, addressing unmet medical needs and improving quality of life for pets affected by cancer. By investing in research and development efforts focused on targeted therapies and immunotherapies, stakeholders can capitalize on opportunities for growth and innovation in the Veterinary Oncology market, ultimately advancing the field of veterinary cancer care and enhancing patient outcomes.

Veterinary Oncology Market Market Segmentation

By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Veterinary Oncology Market Companies

Accuray Inc
Boehringer Ingelheim GmbH
Elanco
Karyopharm Therapeutics Inc
One Health
PetCure Oncology
Regeneus Ltd
Varian Medical Systems
Zoetis

Reasons to Buy the Veterinary Oncology Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Veterinary Oncology Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Veterinary Oncology Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Veterinary Oncology Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Veterinary Oncology Market Size Outlook, $ Million, 2021 to 2030
3.2 Veterinary Oncology Market Outlook by Type, $ Million, 2021 to 2030
3.3 Veterinary Oncology Market Outlook by Product, $ Million, 2021 to 2030
3.4 Veterinary Oncology Market Outlook by Application, $ Million, 2021 to 2030
3.5 Veterinary Oncology Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Veterinary Oncology Industry
4.2 Key Market Trends in Veterinary Oncology Industry
4.3 Potential Opportunities in Veterinary Oncology Industry
4.4 Key Challenges in Veterinary Oncology Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Veterinary Oncology Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Veterinary Oncology Market Outlook by Segments
7.1 Veterinary Oncology Market Outlook by Segments, $ Million, 2021- 2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others

8 North America Veterinary Oncology Market Analysis and Outlook To 2030
8.1 Introduction to North America Veterinary Oncology Markets in 2024
8.2 North America Veterinary Oncology Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Veterinary Oncology Market size Outlook by Segments, 2021-2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others

9 Europe Veterinary Oncology Market Analysis and Outlook To 2030
9.1 Introduction to Europe Veterinary Oncology Markets in 2024
9.2 Europe Veterinary Oncology Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Veterinary Oncology Market Size Outlook by Segments, 2021-2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others

10 Asia Pacific Veterinary Oncology Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Veterinary Oncology Markets in 2024
10.2 Asia Pacific Veterinary Oncology Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Veterinary Oncology Market size Outlook by Segments, 2021-2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others

11 South America Veterinary Oncology Market Analysis and Outlook To 2030
11.1 Introduction to South America Veterinary Oncology Markets in 2024
11.2 South America Veterinary Oncology Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Veterinary Oncology Market size Outlook by Segments, 2021-2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others

12 Middle East and Africa Veterinary Oncology Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Veterinary Oncology Markets in 2024
12.2 Middle East and Africa Veterinary Oncology Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Veterinary Oncology Market size Outlook by Segments, 2021-2030
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Accuray Inc
Boehringer Ingelheim GmbH
Elanco
Karyopharm Therapeutics Inc
One Health
PetCure Oncology
Regeneus Ltd
Varian Medical Systems
Zoetis
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal
Canine
Feline
Equine
By Cancer
Skin Cancers
Lymphomas
Sarcomas
Others